QQQ   315.68 (+0.95%)
AAPL   162.36 (+0.99%)
MSFT   284.05 (+1.26%)
META   207.84 (+1.21%)
GOOGL   100.89 (-0.49%)
AMZN   102.00 (+1.75%)
TSLA   195.28 (+0.72%)
NVDA   273.83 (+1.48%)
NIO   10.46 (+6.41%)
BABA   103.38 (+3.46%)
AMD   97.88 (+1.86%)
T   19.08 (+0.42%)
F   12.29 (+1.99%)
MU   63.09 (-0.71%)
CGC   1.76 (-2.76%)
GE   94.05 (-0.01%)
DIS   98.10 (+1.27%)
AMC   4.97 (-0.60%)
PFE   40.38 (+0.32%)
PYPL   74.39 (+0.28%)
NFLX   338.43 (+1.93%)
QQQ   315.68 (+0.95%)
AAPL   162.36 (+0.99%)
MSFT   284.05 (+1.26%)
META   207.84 (+1.21%)
GOOGL   100.89 (-0.49%)
AMZN   102.00 (+1.75%)
TSLA   195.28 (+0.72%)
NVDA   273.83 (+1.48%)
NIO   10.46 (+6.41%)
BABA   103.38 (+3.46%)
AMD   97.88 (+1.86%)
T   19.08 (+0.42%)
F   12.29 (+1.99%)
MU   63.09 (-0.71%)
CGC   1.76 (-2.76%)
GE   94.05 (-0.01%)
DIS   98.10 (+1.27%)
AMC   4.97 (-0.60%)
PFE   40.38 (+0.32%)
PYPL   74.39 (+0.28%)
NFLX   338.43 (+1.93%)
QQQ   315.68 (+0.95%)
AAPL   162.36 (+0.99%)
MSFT   284.05 (+1.26%)
META   207.84 (+1.21%)
GOOGL   100.89 (-0.49%)
AMZN   102.00 (+1.75%)
TSLA   195.28 (+0.72%)
NVDA   273.83 (+1.48%)
NIO   10.46 (+6.41%)
BABA   103.38 (+3.46%)
AMD   97.88 (+1.86%)
T   19.08 (+0.42%)
F   12.29 (+1.99%)
MU   63.09 (-0.71%)
CGC   1.76 (-2.76%)
GE   94.05 (-0.01%)
DIS   98.10 (+1.27%)
AMC   4.97 (-0.60%)
PFE   40.38 (+0.32%)
PYPL   74.39 (+0.28%)
NFLX   338.43 (+1.93%)
QQQ   315.68 (+0.95%)
AAPL   162.36 (+0.99%)
MSFT   284.05 (+1.26%)
META   207.84 (+1.21%)
GOOGL   100.89 (-0.49%)
AMZN   102.00 (+1.75%)
TSLA   195.28 (+0.72%)
NVDA   273.83 (+1.48%)
NIO   10.46 (+6.41%)
BABA   103.38 (+3.46%)
AMD   97.88 (+1.86%)
T   19.08 (+0.42%)
F   12.29 (+1.99%)
MU   63.09 (-0.71%)
CGC   1.76 (-2.76%)
GE   94.05 (-0.01%)
DIS   98.10 (+1.27%)
AMC   4.97 (-0.60%)
PFE   40.38 (+0.32%)
PYPL   74.39 (+0.28%)
NFLX   338.43 (+1.93%)
NYSE:EHC

Encompass Health - EHC Price Target & Analyst Ratings

$53.13
+0.52 (+0.99%)
(As of 03/30/2023 12:00 AM ET)
Add
Compare
Today's Range
$52.65
$53.37
50-Day Range
$51.55
$63.21
52-Week Range
$44.33
$74.61
Volume
577,569 shs
Average Volume
862,931 shs
Market Capitalization
$5.30 billion
P/E Ratio
19.68
Dividend Yield
1.13%
Price Target
$69.00

Encompass Health Consensus Rating and Price Target (2023)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Analyst Rating

Buy
Based on 7 Analyst Ratings

Consensus Analyst Price Target

$69.00
29.87% Upside
High Prediction$75.00
Average Prediction$69.00
Low Prediction$57.00
TypeCurrent
3/30/22 to 3/30/23
1 Month Ago
2/28/22 to 2/28/23
3 Months Ago
12/30/21 to 12/30/22
1 Year Ago
3/30/21 to 3/30/22
Consensus Rating
Buy
Buy
Buy
Buy
Strong Buy
1 Strong Buy rating(s)
1 Strong Buy rating(s)
1 Strong Buy rating(s)
1 Strong Buy rating(s)
Buy
5 Buy rating(s)
6 Buy rating(s)
5 Buy rating(s)
7 Buy rating(s)
Hold
1 Hold rating(s)
0 Hold rating(s)
0 Hold rating(s)
0 Hold rating(s)
Sell
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
Consensus Price Target$69.00$69.60$64.13$85.25
Predicted Upside29.87% Upside22.20% Upside22.44% Upside24.97% Upside
Get Encompass Health Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for EHC and its competitors with MarketBeat's FREE daily newsletter.

EHC Analyst Ratings By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

EHC Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Encompass Health Stock vs. The Competition

TypeEncompass HealthMedical CompaniesS&P 500
Consensus Rating Score
3.00
2.64
2.47
Consensus RatingBuyBuyHold
Predicted Upside29.87% Upside2,011.77% Upside93.71% Upside
News Sentiment RatingNeutral News
Positive News
Positive News

Historical Target Prices and Ratings

DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
3/14/2023Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageEqual Weight$57.00+7.93%
2/9/2023Deutsche Bank Aktiengesellschaft
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost Target$62.00 ➝ $70.00+15.30%
2/9/2023Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy$70.00 ➝ $75.00+22.97%
2/9/2023Mizuho
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy$65.00 ➝ $69.00+14.13%
2/9/2023Credit Suisse Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOutperform$62.00 ➝ $73.00+20.74%
2/8/2023UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost Target$68.00 ➝ $73.00+24.00%
2/8/2023Stephens
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingOverweight$70.00+18.91%
10/28/2022Raymond James
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetStrong-Buy$65.00 ➝ $72.00+38.12%
8/24/2022Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower Target$82.00 ➝ $66.00+30.38%
8/4/2022BMO Capital Markets
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetOutperform$83.00 ➝ $65.00+23.18%
7/27/2020Jefferies Financial Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetBuy$90.00 ➝ $86.00+29.91%
(Data available from 3/30/2018 forward. View 10+ years of historical ratings with our analyst ratings screener.)












EHC Price Target - Frequently Asked Questions

What is Encompass Health's consensus rating and price target?

According to the issued ratings of 7 analysts in the last year, the consensus rating for Encompass Health stock is Buy based on the current 1 hold rating, 5 buy ratings and 1 strong buy rating for EHC. The average twelve-month price prediction for Encompass Health is $69.00 with a high price target of $75.00 and a low price target of $57.00. Learn more on EHC's analyst rating history.

Do Wall Street analysts like Encompass Health more than its competitors?

Analysts like Encompass Health more than other Medical companies. The consensus rating score for Encompass Health is 3.00 while the average consensus rating score for medical companies is 2.64. Learn more on how EHC compares to other companies.

Does Encompass Health's stock price have much upside?

According to analysts, Encompass Health's stock has a predicted upside of 21.28% based on their 12-month price targets.

What analysts cover Encompass Health?

Encompass Health has been rated by Barclays, Credit Suisse Group, Deutsche Bank Aktiengesellschaft, Mizuho, Stephens, Truist Financial, and UBS Group in the past 90 days.


Stock Ratings Reports and Tools

This page (NYSE:EHC) was last updated on 3/30/2023 by MarketBeat.com Staff